Meilleure Health International Industry Group
- Home ›
- HK ›
- Capital Goods
Meilleure Health International Industry Group Limited, an investment holding company, primarily provides anti-aging health management services in Hong Kong and Mainland China. The last earnings update was 91 days ago. More info.
Add to Portfolio Compare Print
- Meilleure Health International Industry Group has significant price volatility in the past 3 months.
2327 Share Price and Events
7 Day Returns
1 Year Returns
2327 Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Meilleure Health International Industry Group (2327) | -6.2% | -4.7% | -45.5% | 40.2% | 82.1% | 71.8% |
| HK Trade Distributors | 1.6% | 2.6% | -7.3% | 1.1% | -24.1% | -52.9% |
| HK Market | 1% | 3.9% | -7.8% | -4.7% | 17.5% | 2% |
1 Year Return vs Industry and Market
- 2327 outperformed the Trade Distributors industry which returned 1.1% over the past year.
- 2327 outperformed the Market in Hong Kong which returned -4.7% over the past year.
2327 Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Meilleure Health International Industry Group
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Meilleure Health International Industry Group.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 1 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 8.5% |
| Perpetual Growth Rate | 10-Year HK Government Bond Rate | 2% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year HK Govt Bond Rate | 2% |
| Equity Risk Premium | S&P Global | 6.7% |
| Trade Distributors Unlevered Beta | Simply Wall St/ S&P Global | 0.92 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.917 (1 + (1- 25%) (8.06%)) |
0.982 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.98 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2% + (0.982 * 6.65%) |
8.53% |
Discounted Cash Flow Calculation for SEHK:2327 using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Meilleure Health International Industry Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (HKD, Millions) | Source |
Present Value Discounted (@ 8.53%) |
|
|---|---|---|---|
| 2020 | 2.73 | Est @ 84.28% | 2.51 |
| 2021 | 4.36 | Est @ 59.6% | 3.70 |
| 2022 | 6.20 | Est @ 42.32% | 4.85 |
| 2023 | 8.07 | Est @ 30.22% | 5.82 |
| 2024 | 9.83 | Est @ 21.76% | 6.53 |
| 2025 | 11.38 | Est @ 15.83% | 6.97 |
| 2026 | 12.71 | Est @ 11.68% | 7.17 |
| 2027 | 13.83 | Est @ 8.78% | 7.18 |
| 2028 | 14.76 | Est @ 6.75% | 7.07 |
| 2029 | 15.55 | Est @ 5.32% | 6.86 |
| Present value of next 10 years cash flows | HK$58.65 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2029
× (1 + g) ÷ (Discount Rate – g)
= HK$15.55 × (1 + 2%) ÷ (8.53% – 2%) |
HK$242.97 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= HK$242.97 ÷ (1 + 8.53%)10 |
HK$107.16 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= HK$58.65 + HK$107.16 |
HK$165.81 |
| Equity Value per Share (HKD) |
= Total value / Shares Outstanding
= HK$165.81 / 4,271.75 |
HK$0.04 |
| Calculation | Result | |
|---|---|---|
| Value per share (HKD) | From above. | HK$0.04 |
| Current discount | Discount to share price of
HK$0.61
= -1 x (HK$0.61 - HK$0.04) / HK$0.04 |
-1471.6% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Meilleure Health International Industry Group is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Meilleure Health International Industry Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Meilleure Health International Industry Group's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in HKD | HK$0.02 |
| SEHK:2327 Share Price ** | SEHK (2019-07-18) in HKD | HK$0.61 |
| Hong Kong Trade Distributors Industry PE Ratio | Median Figure of 30 Publicly-Listed Trade Distributors Companies | 10.42x |
| Hong Kong Market PE Ratio | Median Figure of 1,510 Publicly-Listed Companies | 10.82x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Meilleure Health International Industry Group.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = SEHK:2327 Share Price ÷ EPS (both in HKD) = 0.61 ÷ 0.02 |
28.35x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Meilleure Health International Industry Group is overvalued based on earnings compared to the HK Trade Distributors industry average.
- Meilleure Health International Industry Group is overvalued based on earnings compared to the Hong Kong market.
Price based on expected Growth
Does
Meilleure Health International Industry Group's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 28.35x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts |
-1.2%per year |
| Global Trade Distributors Industry PEG Ratio | Median Figure of 80 Publicly-Listed Trade Distributors Companies | 1.17x |
| Hong Kong Market PEG Ratio | Median Figure of 479 Publicly-Listed Companies | 0.8x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for Meilleure Health International Industry Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Meilleure Health International Industry Group's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in HKD | HK$0.21 |
| SEHK:2327 Share Price * | SEHK (2019-07-18) in HKD | HK$0.61 |
| Hong Kong Trade Distributors Industry PB Ratio | Median Figure of 59 Publicly-Listed Trade Distributors Companies | 0.79x |
| Hong Kong Market PB Ratio | Median Figure of 2,197 Publicly-Listed Companies | 0.92x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = SEHK:2327 Share Price ÷ Book Value per Share (both in HKD) = 0.61 ÷ 0.21 |
2.92x |
* Primary Listing of Meilleure Health International Industry Group.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Meilleure Health International Industry Group is overvalued based on assets compared to the HK Trade Distributors industry average.
Value checks
We assess Meilleure Health International Industry Group's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Trade Distributors industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Trade Distributors industry average (and greater than 0)? (1 check) Meilleure Health International Industry Group has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
2327 Future Performance
- No analysts cover Meilleure Health International Industry Group, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Meilleure Health International Industry Group's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2%.
Growth vs Market Checks
- Meilleure Health International Industry Group's earnings growth is expected to exceed the Hong Kong market average.
- Meilleure Health International Industry Group's revenue growth is positive but not above the Hong Kong market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| SEHK:2327 Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts | -1.2% |
| SEHK:2327 Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts | 5.3% |
| Hong Kong Trade Distributors Industry Earnings Growth Rate | Market Cap Weighted Average | 9.7% |
| Asia Trade Distributors Industry Revenue Growth Rate | Market Cap Weighted Average | 12% |
| Hong Kong Market Earnings Growth Rate | Market Cap Weighted Average | -5.2% |
| Hong Kong Market Revenue Growth Rate | Market Cap Weighted Average | 13.5% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (6 months ago) | See Below |
| Future Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
| Date (Data in HKD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-12-31 | 266 | 1 | ||
| 2020-12-31 | 245 | 1 | ||
| 2019-12-31 | 224 | 1 |
| Date (Data in HKD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 231 | 18 | 81 |
| 2018-09-30 | 181 | -38 | 81 |
| 2018-06-30 | 132 | -94 | 81 |
| 2018-03-31 | 101 | -79 | 81 |
| 2017-12-31 | 69 | -63 | 80 |
| 2017-09-30 | 83 | -177 | 60 |
| 2017-06-30 | 97 | -291 | 40 |
| 2017-03-31 | 82 | -276 | 37 |
| 2016-12-31 | 67 | -261 | 34 |
*GAAP earnings excluding extraordinary items.
High Growth Checks
- Meilleure Health International Industry Group's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
- Meilleure Health International Industry Group's revenue is expected to grow by 5.3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (6 months ago) | See Below |
| Future Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
All data from Meilleure Health International Industry Group Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in HKD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-12-31 | ||||
| 2020-12-31 | ||||
| 2019-12-31 |
| Date (Data in HKD Millions) | EPS * |
|---|---|
| 2018-12-31 | 0.02 |
| 2018-09-30 | 0.02 |
| 2018-06-30 | 0.02 |
| 2018-03-31 | 0.02 |
| 2017-12-31 | 0.02 |
| 2017-09-30 | 0.02 |
| 2017-06-30 | 0.01 |
| 2017-03-31 | 0.01 |
| 2016-12-31 | 0.01 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Unable to establish if Meilleure Health International Industry Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
Future performance checks
We assess Meilleure Health International Industry Group's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Hong Kong market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Asia market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Meilleure Health International Industry Group has a total score of 1/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
2327 Past Performance
How has Meilleure Health International Industry Group performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Meilleure Health International Industry Group has delivered over 20% year on year earnings growth in the past 5 years.
- Meilleure Health International Industry Group's 1-year earnings growth is less than its 5-year average (0.6% vs 20.9%)
- Meilleure Health International Industry Group's earnings growth has not exceeded the HK Trade Distributors industry average in the past year (0.6% vs 7.8%).
Earnings and Revenue History
All data from Meilleure Health International Industry Group Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in HKD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 230.54 | 80.54 | 33.19 | |
| 2018-09-30 | 181.45 | 80.89 | 30.94 | |
| 2018-06-30 | 132.37 | 81.25 | 28.70 | |
| 2018-03-31 | 100.54 | 80.66 | 26.28 | |
| 2017-12-31 | 68.71 | 80.07 | 23.86 | |
| 2017-09-30 | 82.69 | 59.89 | 22.77 | |
| 2017-06-30 | 96.67 | 39.71 | 21.69 | |
| 2017-03-31 | 81.67 | 37.05 | 18.76 | |
| 2016-12-31 | 66.66 | 34.38 | 15.83 | |
| 2015-12-31 | 76.00 | 10.31 | 9.85 | |
| 2015-09-30 | 16.58 | -1.44 | 8.05 | |
| 2015-06-30 | 12.96 | 0.27 | 7.84 | |
| 2015-03-31 | 9.34 | 1.98 | 7.64 | |
| 2014-12-31 | 15.74 | 0.76 | 7.72 | |
| 2014-09-30 | 22.14 | -0.45 | 7.80 | |
| 2014-06-30 | 28.61 | 44.38 | 8.93 | |
| 2014-03-31 | 35.08 | 89.22 | 10.07 | |
| 2013-12-31 | 34.04 | 87.14 | 11.96 | |
| 2013-09-30 | 32.99 | 85.05 | 13.86 | |
| 2013-06-30 | 34.32 | 63.40 | 13.38 | |
| 2013-03-31 | 35.65 | 41.75 | 12.89 | |
| 2012-12-31 | 64.99 | 61.42 | 14.90 | |
| 2012-09-30 | 94.32 | 81.09 | 16.91 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Meilleure Health International Industry Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Meilleure Health International Industry Group used its assets more efficiently than the HK Trade Distributors industry average last year based on Return on Assets.
- Meilleure Health International Industry Group has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Meilleure Health International Industry Group's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Trade Distributors industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Meilleure Health International Industry Group has a total score of 3/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
2327 Health
How is Meilleure Health International Industry Group's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Meilleure Health International Industry Group's finances.
The net worth of a company is the difference between its assets and liabilities.
- Meilleure Health International Industry Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Meilleure Health International Industry Group's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Debt is covered by short term assets, assets are 2.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Meilleure Health International Industry Group Company Filings, last reported 6 months ago.
| Date (Data in HKD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 821.63 | 220.39 | 162.13 |
| 2018-09-30 | 821.63 | 220.39 | 162.13 |
| 2018-06-30 | 762.83 | 211.30 | 63.80 |
| 2018-03-31 | 762.83 | 211.30 | 63.80 |
| 2017-12-31 | 686.46 | 171.38 | 51.84 |
| 2017-09-30 | 686.46 | 171.38 | 51.84 |
| 2017-06-30 | 621.64 | 126.85 | 46.86 |
| 2017-03-31 | 621.64 | 126.85 | 46.86 |
| 2016-12-31 | 562.16 | 50.16 | 57.12 |
| 2015-12-31 | 314.92 | 0.00 | 197.41 |
| 2015-09-30 | 308.24 | 0.00 | 236.45 |
| 2015-06-30 | 308.24 | 0.00 | 236.45 |
| 2015-03-31 | 97.24 | 100.00 | 52.29 |
| 2014-12-31 | 97.24 | 100.00 | 52.29 |
| 2014-09-30 | 98.83 | 99.84 | 46.58 |
| 2014-06-30 | 98.83 | 99.84 | 46.58 |
| 2014-03-31 | 95.21 | 99.99 | 45.10 |
| 2013-12-31 | 95.21 | 99.99 | 45.10 |
| 2013-09-30 | 99.29 | 89.00 | 56.42 |
| 2013-06-30 | 99.29 | 89.00 | 56.42 |
| 2013-03-31 | 615.94 | 179.01 | 94.73 |
| 2012-12-31 | 615.94 | 179.01 | 94.73 |
| 2012-09-30 | 617.68 | 240.57 | 215.08 |
- Meilleure Health International Industry Group's level of debt (26.8%) compared to net worth is satisfactory (less than 40%).
- The level of debt compared to net worth has been reduced over the past 5 years (105% vs 26.8% today).
- Debt is not well covered by operating cash flow (8.1%, less than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 4.9x coverage).
Financial health checks
We assess Meilleure Health International Industry Group's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Meilleure Health International Industry Group has a total score of 5/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
2327 Dividends
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
HK$2,000 of
Meilleure Health International Industry Group
shares you are expected to receive
HK$0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate Meilleure Health International Industry Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Meilleure Health International Industry Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
| Hong Kong Trade Distributors Industry Average Dividend Yield | Market Cap Weighted Average of 12 Stocks | 4.7% |
| Hong Kong Market Average Dividend Yield | Market Cap Weighted Average of 978 Stocks | 3.6% |
| Hong Kong Minimum Threshold Dividend Yield | 10th Percentile | 1.2% |
| Hong Kong Bottom 25% Dividend Yield | 25th Percentile | 2.1% |
| Hong Kong Top 25% Dividend Yield | 75th Percentile | 5.7% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in HK$) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2021-12-31 | ||
| 2020-12-31 | ||
| 2019-12-31 |
| Date (Data in HK$) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-04-18 | 0.000 | 0.000 |
| 2019-04-01 | 0.000 | 0.000 |
| 2018-09-20 | 0.000 | 0.000 |
| 2018-08-30 | 0.000 | 0.000 |
| 2018-04-27 | 0.006 | 1.459 |
| 2018-03-28 | 0.006 | 1.384 |
| 2017-09-28 | 0.006 | 1.671 |
| 2017-08-29 | 0.006 | 1.688 |
| 2013-12-12 | 0.000 | 0.000 |
| 2013-11-25 | 0.000 | 0.000 |
| 2013-06-19 | 0.000 | 0.000 |
| 2013-06-13 | 0.000 | 0.000 |
| 2012-06-04 | 0.021 | 5.343 |
| 2012-05-24 | 0.021 | 6.551 |
| 2011-07-12 | 0.060 | 17.164 |
| 2011-06-27 | 0.060 | 13.072 |
| 2010-07-26 | 0.013 | 2.656 |
| 2010-07-16 | 0.013 | 2.659 |
| 2009-06-22 | 0.010 | 3.114 |
| 2008-07-25 | 0.010 | 6.472 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as Meilleure Health International Industry Group has not reported any payouts.
- Unable to verify if Meilleure Health International Industry Group's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess Meilleure Health International Industry Group's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Meilleure Health International Industry Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Meilleure Health International Industry Group has a total score of 0/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
2327 Management
CEO
| COMPENSATION | HK$540,000 |
| AGE | 36 |
| TENURE AS CEO | 5.8 years |
CEO Bio
Ms. Wen Chuan Zhou has been the Chief Executive Officer and Executive Director of U-Home Group Holdings Limited since September 23, 2013. Ms. Zhou has been Vice Chairman of U-Home Group Holdings Limited. She obtained a master degree in Business Administration from the Chinese University of Hong Kong in 2011 and a master degree in Food Science and a bachelor degree in Science in Food Nutrition and Health from the University of British Columbia in 2008 and 2007 respectively.
CEO Compensation
- Wen Chuan's compensation has been consistent with company performance over the past year, both up more than 20%.
- Wen Chuan's remuneration is lower than average for companies of similar size in Hong Kong.
Management Team Tenure
Average tenure and age of the Meilleure Health International Industry Group management team in years:
- The average tenure for the Meilleure Health International Industry Group management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team
Xuzhou Zhou
Co-Chairmen of the Board
HK$500K
63
Wentao Zeng
Co-Chairmen & Executive Director
HK$120K
56
0.2 yrs
Wen Chuan Zhou
Vice Chairman & CEO
HK$540K
36
5.8 yrs
Man Fai Shek
Financial Controller & Company Secretary
44
Man Chun Chu
Human Resources Manager
59
Pu Chun Feng
Chief of R&D Dept - Kunming Jida Pharmaceutical Company Ltd and Director of R&D Dept - Kunming Jida
47
Chen Bang Hua
President of Jiwa Rintech Holdings Limited and Executive Director of Jiwa Rintech Holdings Limited
64
Chun Xia Liu
Quality Director of KJP and Director of Yunnan Jiwa Pharm-Tech Co Ltd
57
22.3 yrs
Dong Mei Luo
Executive Assistant to Chairman and COO of Kunming Jida Pharmaceutical Company Ltd
50
Board of Directors Tenure
Average tenure and age of the Meilleure Health International Industry Group board of directors in years:
- The tenure for the Meilleure Health International Industry Group board of directors is about average.
Board of Directors
Xuzhou Zhou
Co-Chairmen of the Board
HK$500K
63
0.2 yrs
Wentao Zeng
Co-Chairmen & Executive Director
HK$120K
56
Wen Chuan Zhou
Vice Chairman & CEO
HK$540K
36
Chen Bang Hua
President of Jiwa Rintech Holdings Limited and Executive Director of Jiwa Rintech Holdings Limited
64
Chun Xia Liu
Quality Director of KJP and Director of Yunnan Jiwa Pharm-Tech Co Ltd
57
Guanjiang Gao
Independent Non-Executive Director
HK$120K
66
5.9 yrs
Wilton Chau
Independent Non-Executive Director
HK$120K
58
5.9 yrs
Zhenhua Mao
Non-Executive Director
HK$120K
55
3.8 yrs
Peng Wu
Independent Non-Executive Director
36
0.2 yrs
Who owns this company?
Recent Insider Trading
- More shares have been bought than sold by Meilleure Health International Industry Group individual insiders in the past 3 months.
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (HK$) | Value (HK$) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 14. Jun 19 | Buy | Xuzhou Zhou | Individual | 14. Jun 19 | 14. Jun 19 | 8,772,000 | HK$0.65 | HK$5,742,995 | ||
| 12. Jun 19 | Buy | Xuzhou Zhou | Individual | 12. Jun 19 | 12. Jun 19 | 1,200,000 | HK$0.66 | HK$792,002 | ||
| 04. Jun 19 | Buy | Xuzhou Zhou | Individual | 04. Jun 19 | 04. Jun 19 | 6,600,000 | HK$0.63 | HK$4,129,609 | ||
| 20. May 19 | Buy | Xuzhou Zhou | Individual | 20. May 19 | 20. May 19 | 4,500,000 | HK$0.74 | HK$3,312,435 | ||
| 17. May 19 | Buy | Xuzhou Zhou | Individual | 17. May 19 | 17. May 19 | 3,000,000 | HK$0.81 | HK$2,430,003 | ||
| 27. Apr 19 | Buy | Wentao Zeng | Individual | 26. Apr 19 | 26. Apr 19 | 15,000,000 | HK$0.91 | HK$13,649,999 | ||
| 27. Apr 19 | Buy | Xuzhou Zhou | Individual | 26. Apr 19 | 26. Apr 19 | 43,002,000 | HK$0.91 | HK$39,131,818 | ||
| 11. Apr 19 | Sell | Eagle Best Limited | Company | 09. Apr 19 | 09. Apr 19 | -2,292,000 | HK$1.43 | HK$-3,276,413 | ||
| 11. Apr 19 | Sell | Eagle Best Limited | Company | 10. Apr 19 | 10. Apr 19 | -9,180,000 | HK$1.48 | HK$-13,565,277 | ||
| 10. Apr 19 | Sell | Eagle Best Limited | Company | 08. Apr 19 | 08. Apr 19 | -3,390,000 | HK$1.50 | HK$-5,096,537 | ||
| 10. Apr 19 | Sell | Chi Wai Chau | Individual | 08. Apr 19 | 08. Apr 19 | -90,000 | HK$1.60 | HK$-144,000 | ||
| 04. Apr 19 | Sell | Eagle Best Limited | Company | 02. Apr 19 | 02. Apr 19 | -1,248,000 | HK$1.17 | HK$-1,463,900 | ||
| 19. Oct 18 | Buy | Xuzhou Zhou | Individual | 18. Oct 18 | 18. Oct 18 | 1,200,000 | HK$0.42 | HK$499,438 | ||
| 12. Oct 18 | Buy | Wen Chuan Zhou | Individual | 12. Oct 18 | 12. Oct 18 | 1,320,000 | HK$0.40 | HK$526,017 | ||
| 12. Oct 18 | Buy | Xuzhou Zhou | Individual | 12. Oct 18 | 12. Oct 18 | 126,000 | HK$0.41 | HK$51,030 | ||
| 11. Oct 18 | Buy | Wen Chuan Zhou | Individual | 11. Oct 18 | 11. Oct 18 | 1,200,000 | HK$0.40 | HK$479,999 | ||
| 26. Sep 18 | Buy | Xuzhou Zhou | Individual | 24. Sep 18 | 24. Sep 18 | 1,848,000 | HK$0.41 | HK$766,913 | ||
| 18. Sep 18 | Buy | Xuzhou Zhou | Individual | 18. Sep 18 | 18. Sep 18 | 2,460,000 | HK$0.36 | HK$875,998 | ||
| 20. Jul 18 | Buy | Xuzhou Zhou | Individual | 19. Jul 18 | 19. Jul 18 | 1,080,000 | HK$0.43 | HK$462,671 | ||
Management checks
We assess Meilleure Health International Industry Group's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Meilleure Health International Industry Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
2327 News
Simply Wall St News
Does Meilleure Health International Industry Group Limited's (HKG:2327) CEO Pay Compare Well With Peers?
See our latest analysis for Meilleure Health International Industry Group How Does Wen Chuan Zhou's Compensation Compare With Similar Sized Companies? … Our data indicates that Meilleure Health International Industry Group Limited is worth HK$2.8b, and total annual CEO compensation is HK$540k. … Meilleure Health International Industry Group Limited is currently paying its CEO below what is normal for companies of its size.
Simply Wall St - – Full articleTaking A Look At Meilleure Health International Industry Group Limited's (HKG:2327) ROE
Check out our latest analysis for Meilleure Health International Industry Group How Do I Calculate Return On Equity? … The formula for return on equity is: Return on Equity = Net Profit ÷ Shareholders' Equity Or for Meilleure Health International Industry Group: 9.9% = HK$81m ÷ HK$822m (Based on the trailing twelve months to December 2018.) Most know that net profit is the total earnings after all expenses, but the concept of shareholders' equity is a little more complicated. … Combining Meilleure Health International Industry Group's Debt And Its 9.9% Return On Equity Meilleure Health International Industry Group has a debt to equity ratio of 0.27, which is far from excessive.
Simply Wall St - – Full articleHow Good Is Meilleure Health International Industry Group Limited (HKG:2327) At Creating Shareholder Value?
The formula for calculating the return on capital employed is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Meilleure Health International Industry Group: 0.055 = HK$57m ÷ (HK$1.3b - HK$268m) (Based on the trailing twelve months to December 2018.) Therefore, Meilleure Health International Industry Group has an ROCE of 5.5%. … View our latest analysis for Meilleure Health International Industry Group Is Meilleure Health International Industry Group's ROCE Good? … How Meilleure Health International Industry Group's Current Liabilities Impact Its ROCE Liabilities, such as supplier bills and bank overdrafts, are referred to as current liabilities if they need to be paid within 12 months.
Simply Wall St - – Full articleHave Insiders Been Buying Meilleure Health International Industry Group Limited (HKG:2327) Shares This Year?
So before you buy or sell Meilleure Health International Industry Group Limited (HKG:2327), you may well want to know whether insiders have been buying or selling. … See our latest analysis for Meilleure Health International Industry Group. … The good news for Meilleure Health International Industry Group share holders is that insiders were buying at near the current price.
Simply Wall St - – Full articleWhy Meilleure Health International Industry Group Limited's (HKG:2327) High P/E Ratio Isn't Necessarily A Bad Thing
We'll show how you can use Meilleure Health International Industry Group Limited's (HKG:2327) P/E ratio to inform your assessment of the investment opportunity. … Meilleure Health International Industry Group has a P/E ratio of 52.97, based on the last twelve months. … View our latest analysis for Meilleure Health International Industry Group?
Simply Wall St - – Full articleInterested In Meilleure Health International Industry Group Limited (HKG:2327)? Here's How It Performed Recently
Below, I will examine Meilleure Health International Industry Group Limited's (HKG:2327) track record on a high level, to give you some insight into how the company has been performing against its long term trend and its industry peers. … Check out our latest analysis for Meilleure Health International Industry Group? … Did 2327 perform better than its track record and industry.
Simply Wall St - – Full articleHow Much Did Meilleure Health International Industry Group Limited's (HKG:2327) CEO Pocket Last Year?
Wen Zhou became the CEO of Meilleure Health International Industry Group Limited (HKG:2327) in 2013. … View our latest analysis for Meilleure Health International Industry Group? … At the time of writing our data says that Meilleure Health International Industry Group Limited has a market cap of HK$4.3b, and is paying total annual CEO compensation of HK$540k.
Simply Wall St - – Full articleCan You Imagine How Chuffed Meilleure Health International Industry Group's Shareholders Feel About Its 149% Share Price Gain?
For example, the Meilleure Health International Industry Group Limited (HKG:2327) share price has soared 149% in the last three years. … Check out our latest analysis for Meilleure Health International Industry Group. … Meilleure Health International Industry Group was able to grow its EPS at 429% per year over three years, sending the share price higher.
Simply Wall St - – Full articleIs Meilleure Health International Industry Group Limited (HKG:2327) Struggling With Its 2.4% Return On Capital Employed?
Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … Understanding Return On Capital Employed (ROCE). … How Do You Calculate Return On Capital Employed
Simply Wall St - – Full articleWhat Meilleure Health International Industry Group Limited's (HKG:2327) ROE Can Tell Us
To keep the lesson grounded in practicality, we'll use ROE to better understand Meilleure Health International Industry Group Limited (HKG:2327). … Over the last twelve months Meilleure Health International Industry Group has recorded a ROE of 11%. … Check out our latest analysis for Meilleure Health International Industry Group?
Simply Wall St - – Full article2327 Company Info
Description
Meilleure Health International Industry Group Limited, an investment holding company, primarily provides anti-aging health management services in Hong Kong and Mainland China. It operates through Trading of Health Care Products, Agency Service, Property Development, Property Investment and Leasing Business, and Health Care Related Business segments. The company offers health check and personalized precision health management solutions, as well as anti-aging treatment services through its clinics. It is also involved in the trading of health care products, and building and chemical materials; sale of medicines; leasing of building materials; provision of real estate agency services; and development of residential properties. The company was formerly known as U-Home Group Holdings Limited and changed its name to Meilleure Health International Industry Group Limited in March 2017. Meilleure Health International Industry Group Limited is headquartered in Admiralty, Hong Kong.
Details
| Name: | Meilleure Health International Industry Group Limited |
| 2327 | |
| Exchange: | SEHK |
| Founded: | |
| HK$2,733,921,687 | |
| 4,271,752,636 | |
| Website: | http://www.meilleure.com.cn |
| Address: |
Meilleure Health International Industry Group Limited Tower 1, Unit 2906, Admiralty, Hong Kong |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| SEHK | 2327 | Ordinary Shares | The Stock Exchange of Hong Kong Ltd. | HK | HKD | 14. Oct 2003 |
Number of employees
Current staff
Industry
| Trading Companies and Distributors | |
| Capital Goods |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/07/18 12:45 |
| End of day share price update: | 2019/07/18 00:00 |
| Last estimates confirmation: | 2019/07/06 |
| Last earnings filing: | 2019/04/18 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
